| abstract |
A compound of formula (I) below, or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof. (I) where R a , R b , R c , R d , X 1 , X 2 , R 1 -R 4 , W, Z, and L are defined as in the Summary of the Invention section. Further disclosed are methods of using the above compounds, salts, stereoisomers, solvates or prodrugs and pharmaceutical compositions comprising the same for treating HBV infection. |